← Open Payments lookup

LIAM DONOVAN: Open Payments

NPI 1083452502 · GLEN BURNIE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$3,548 in 155 payments from 20 companies in 2025. Trend: 2023 $0 · 2024 $1,129 · 2025 $3,548

Food & beverage: $3,362Education: $186
CompanyPaymentsAmount
Teva Pharmaceuticals USA, Inc.15$564
E.R. Squibb & Sons, L.L.C.15$425
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)19$396
Lundbeck LLC22$350
Neurocrine BioSciences, Inc.14$277
Alkermes, Inc.12$246
Otsuka America Pharmaceutical, Inc.4$210
Janssen Pharmaceuticals, Inc6$174
ABBVIE INC.14$135
Vanda Pharmaceuticals Inc.5$118

Products named: REXULTI, COBENFY, CAPLYTA, INGREZZA, ARISTADA, AUSTEDO XR, UZEDY, INVEGA SUSTENNA.

Industry payments across MD — which companies pay providers there.